Method and apparatus for noninvasively monitoring hemoglobin concentration and oxygen saturation

• US 6,714,805 B2
• Filed: 04/19/2002
• Issued: 03/30/2004
• Est. Priority Date: 04/19/2001
• Status: Active Grant

• Current Assignee: Samsung Electronics Co. Ltd.
• Original Assignee: Samsung Electronics Co. Ltd.
• Inventors: Yoon, Gil-won, Jeon, Kye-jin
• Primary Examiner(s): Hinderburg, Max F.
• Assistant Examiner(s): KREMER, MATTHEW J
• Application Number:
  US10/125,740
• Publication Number:
  US 20030009090A1
• Time in Patent Office: 711 Days
• Field of Search: 600/309-310, 600/322-326, 600/335, 600/328
• US Class Current: 600/323
• CPC Class Codes: A61B 5/14535 for measuring haematocrit
• CPC Class Codes: A61B 5/14551 for measuring blood gases

Abstract

A method and apparatus for noninvasively monitoring hemoglobin concentration and oxygen saturation, wherein the method includes selecting at least two wavelengths from a region of wavelengths in which an extinction coefficient for water is smaller that for hemoglobin, the at least two wavelengths including at least two isobestic wavelengths; sequentially radiating incident light beams having the selected wavelengths onto a predetermined site of a body which includes a blood vessel; receiving, at another site of the body, light beams sequentially transmitted through the predetermined site and converting the received light beams into electrical signals; calculating the light attenuation variation caused by pulses of blood for the respective wavelengths from the electrical signals; obtaining at least one ratio of the light attenuation variation between the selected wavelengths; and calculating the hemoglobin concentration C_Hb in blood using the calculated at least one ratio of the light attenuation variation between the wavelengths.

Claims

1. A method for noninvasively monitoring hemoglobin concentration and oxygen saturation comprising:

(a) selecting at least two wavelengths from a region of wavelengths in which an extinction coefficient for water is smaller than an extinction coefficient for hemoglobin, the at least two wavelengths including at least two isobestic wavelengths;

(b) sequentially radiating incident light beams having the selected wavelengths onto a predetermined site of a body that includes a blood vessel, wherein the predetermined site includes the blood vessel whose thickness varies with pulses no greater than a predetermined value;

(c) receiving, at another site of the body, light beams sequentially transmitted through the predetermined site and converting the received light beams into electrical signals;

(d) calculating the light attenuation variation caused by pulses of blood for the respective wavelengths from the electrical signals;

(e) obtaining at least one ratio of the light attenuation variation between the selected wavelengths; and

(f) calculating the hemoglobin concentration C_Hb in blood using the calculated at least one ratio of the light attenuation variation between the wavelengths.

2. The method as claimed in claim 1, wherein the at least two wavelengths selected in (a) comprise two wavelengths between which the difference in the light attenuation variation with respect to hematocrit H is greatest.

3. The method as claimed in claim 2, wherein the at least two wavelengths selected in (a) are 569 nm and 805 nm.

4. The method as claimed in claim 2, wherein the at least two wavelengths selected in (a) are 546 nm and 805 nm.

5. The method as claimed in claim 1, wherein the isobestic wavelengths are selected from the group consisting of 422 nm, 453 nm, 499 nm, 529 nm, 546 nm, 569 nm, 584 nm, 805 nm, and 1300 nm.

6. The method as claimed in claim 1, wherein the predetermined value is 500 μ

m.

7. The method as claimed in claim 1, wherein, in (b), the incident light beams are sequentially radiated while applying a variable pressure to the predetermined site.

8. The method as claimed in claim 1, wherein, in (d), the light attenuation variation for each wavelength caused by pulses of blood is obtained as a ratio between a time variant component and a time invariant component of the electrical signals.

9. The method as claimed in claim 1, wherein (f) comprises:

(f1) generating the model equation below based upon the relation between hemoglobin concentrations measured invasively and the at least one ratio obtained in (e);

$C_{\mathrm{Hb}}=\underset{i}{\overset{p}{\sum <br><br>}}<br><br>\underset{j}{\overset{p}{\sum <br><br>}}<br><br>A_{\mathrm{ij}}<br><br>R_{\mathrm{ij}},\mathrm{where}<br><br>\text{\hspace{1em}<br><br>}<br><br>R_{\mathrm{ij}}=1<br><br>\text{\hspace{1em}<br><br>}<br><br>\mathrm{if}<br><br>\text{\hspace{1em}<br><br>}<br><br>i=j$

where A_ij is a coefficient for ratio R_ij;

R_ij is the ratio of the light attenuation variation between the wavelengths obtained in (e); and

p is an integer greater than or equal to 2; and

(f2) calculating the hemoglobin concentration C_Hb by substituting the at least one ratio obtained in (e) into the model equation generated in (f1).

10. The method as claimed in claim 9, wherein, in (f), the coefficient A_ij is statistically obtained by a principle component regression (PCR) method.

11. The method as claimed in claim 9, wherein, in (f), the coefficient A_ij is statistically obtained by a partial least squares regression (PLSR) method.

12. A method for noninvasively monitoring hemoglobin concentration and oxygen saturation comprising:

(a) selecting at least two wavelengths from a region of wavelengths in which an extinction coefficient for water is smaller than an extinction coefficient for hemoglobin, the at least two wavelengths including at least two isobestic wavelengths;

(b) sequentially radiating incident light beams having the selected wavelengths onto a predetermined site of a body that includes a blood vessel;

(c) receiving, at another site of the body, light beams sequentially transmitted through the predetermined site and converting the received light beams into electrical signals;

(d) calculating the light attenuation variation caused by pulses of blood for the respective wavelengths from the electrical signals;

(e) obtaining at least one ratio of the light attenuation variation between the selected wavelengths; and

(f) calculating the hemoglobin concentration C_Hb in blood using the calculated at least one ratio of the light attenuation variation between the wavelengths,

wherein, when the at least two wavelengths selected in (a) are λ

₁ and λ

₂, the hemoglobin concentration C_Hb is calculated in (f) by the formula below using a ratio R₁₂ of light attenuation variation between the two wavelengths λ

₁ and λ

₂ obtained in (e);

$C_{\mathrm{Hb}}=\frac{{35}^2<br><br>\left({\mathrm{\varepsilon <br><br>}}_1-R_{12}<br><br>{\mathrm{\varepsilon <br><br>}}_2\right)}{k_1<br><br>a_1-k_a<br><br>a_a<br><br>R_{12}}+35$

where ε

₁ and ε

₂ denote the extinction coefficients for the wavelengths λ

₁ and λ

₂, respectively, k₁ and k_a are constants dependant upon the characteristics of scattering and absorbing the incident light beams at the predetermined site and the wavelengths λ

₁ and λ

₂, and a₁ and a_a are constants dependent upon the size of scattering particles, the refractive indexes of hemoglobin and plasma, and the wavelengths λ

₁ and λ

₂.

13. A method for noninvasively monitoring hemoglobin concentration and oxygen saturation comprising:

(a) selecting at least two wavelengths from a region of wavelengths in which an extinction coefficient for water is smaller than an extinction coefficient for hemoglobin, the at least two wavelengths including at least two isobestic wavelengths;

(b) sequentially radiating incident light beams having the selected wavelengths onto a predetermined site of a body that includes a blood vessel;

(c) receiving, at another site of the body, light beams sequentially transmitted through the predetermined site and converting the received light beams into electrical signals;

(d) calculating the light attenuation variation caused by pulses of blood for the respective wavelengths from the electrical signals;

(e) obtaining at least one ratio of the light attenuation variation between the selected wavelengths;

(f) calculating the hemoglobin concentration C_Hb in blood using the calculated at least one ratio of the light attenuation variation between the wavelengths; and

(g) calculating oxygen saturation S using the hemoglobin concentration C_Hb calculated in (f), wherein (g) includes;

(g1) selecting one wavelength λ

_X of the at least two wavelengths selected in (a) and a wavelength λ

_O having greatly different extinction coefficients depending upon the form of hemoglobin;

(g2) obtaining the light attenuation variation for the wavelength λ

_O selected in (g1) by performing (b) through (d);

(g3) obtaining a ratio R_OX between the light attenuation variation for the wavelength λ

_O, obtained in (g2) and the light attenuation variation for the wavelength λ

_X obtained in (d); and

(g4) calculating the oxygen saturation S in blood using the ratio obtained in (g3) and the hemoglobin concentration C_Hb calculated in (f),

wherein, in (g4), the oxygen saturation S is calculated by the formula below;

$R_{\mathrm{OX}}=\frac{\left[{\mathrm{\varepsilon <br><br>}}_{{\mathrm{HbO}}_2,O}<br><br>S+{\mathrm{\varepsilon <br><br>}}_{\mathrm{Hb},O}<br><br>\left(1-S\right)\right]<br><br>C_{\mathrm{Hb}}+k_O<br><br>a_O<br><br>H<br><br>\left(1-H\right)}{{\mathrm{\varepsilon <br><br>}}_{\mathrm{Hb},X}<br><br>C_{\mathrm{Hb}}+k_X<br><br>a_X<br><br>H<br><br>\left(1-H\right)}$

where ε

_HbO2,O indicates an extinction coefficient for oxyhemoglobin at the wavelength λ

_O;

ε

_Hb,O indicates the extinction coefficient for hemoglobin at the wavelength λ

_O;

ε

_Hb,X indicates the extinction coefficient for hemoglobin at the wavelength λ

_X;

k_X and k_O, are constants dependent upon the characteristics of scattering and absorbing the incident light beams at the predetermined site and the wavelengths λ

_O, and λ

_X, a_X and a_O are constants dependent upon the size of scattering particles, the refractive indexes of hemoglobin and plasma, and the wavelengths λ

_O and λ

_X, and H denotes the hematocrit value approximately equal to C_Hb/35.

14. An apparatus for noninvasively monitoring hemoglobin concentration and oxygen saturation, comprising:

a light radiation unit for sequentially radiating incident light beams having at least two wavelengths selected from a region in which an extinction coefficient for water is smaller than an extinction coefficient for hemoglobin, onto a predetermined site of the body that includes a blood vessel;

a photodetector unit for receiving, at another site of the body, light beams transmitted through the predetermined site, converting the received light beams into an electrical signal, and outputting the converted electrical signal;

a variation calculation unit for calculating light attenuation variation for each of the selected at least two wavelengths from the electrical signal and outputting the calculated light attenuation variation;

a ratio calculation unit for calculating at least one ratio among the light attenuation variations sequentially input from the variation calculation unit and outputting the calculated at least one ratio of the light attenuation variations;

a concentration calculation unit for calculating hemoglobin concentration in blood from the at least one ratio and outputting the calculated hemoglobin concentration; and

a compression unit for compressing the predetermined site with a variable pressure,

wherein the predetermined site is compressed by the compression unit to vary a thickness of the blood vessel with no pulses no greater than a predetermined value, and

wherein the at least two wavelengths are externally selected to include at least two isobestic wavelengths.

15. The apparatus as claimed in claim 14, further comprising an oxygen saturation calculation unit for calculating oxygen saturation using the hemoglobin concentration input from the concentration calculation unit.

16. The apparatus as claimed in claim 15, further comprising a display unit for displaying the hemoglobin concentration and the oxygen saturation.

17. The apparatus as claimed in claim 14, further comprising a display unit for displaying the hemoglobin concentration.

18. The apparatus as claimed in claim 14, wherein the light radiation unit comprises a light emitting diode (LED) that sequentially radiates the incident light beams onto the predetermined site.

19. The apparatus as claimed in claim 14, wherein the light radiation unit comprises a laser diode (Ld) that sequentially radiates the incident light beams onto the predetermined site.

20. The apparatus as claimed in claim 14, wherein the light radiation unit comprises a lamp that sequentially radiates the incident light beams onto the predetermined site.

21. The apparatus as claimed in claim 14, wherein the light radiation unit comprises a photodiode that is made of a material selected from the group consisting of silicon (Si), germanium (Ge), and indium gallium arsenide (InGaAs) and sequentially radiates the incident light beams onto the predetermined site.

22. The apparatus as claimed in claim 14, further comprising at least one correction member having light transmitting and scattering characteristics similar to a soft issue of the body and disposed on an optical path of the incident light beams and on the outside of the predetermined site,

wherein the thickness of the at least one correction member on the optical path is variable.

23. The apparatus as claimed in claim 22, wherein the at least one correction member is formed of one of the group consisting of:

a liquid implemented in a form of gel, polystyrene beads, an intra-lipid, and a milk solution.

24. The apparatus as claimed in claim 14, wherein the light radiation unit sequentially radiates the incident light beams onto the predetermined site while compressing the predetermined site with a pressure by a predetermined variable weight of the light radiation unit.

25. The apparatus as claimed in claim 14, wherein the light radiation unit sequentially radiates the incident light beams onto the predetermined site while the pressure is applied by the compression unit.

26. The apparatus as claimed in claim 14, further comprising:

an amplifier for amplifying the electrical signal output from the photodetector units and outputting the amplified electrical signal;

a low-pass filter for filtering the low-frequency components of the amplified electrical signal and outputting the filtered low-frequency component; and

an analog-to-digital converter for convening the filtered low-frequency component in analog form into digital form and outputting the converted digital low-frequency component to the variation calculation unit,

wherein the variation calculation unit calculates the light attenuation variation for the respective selected wavelengths from the digital low-frequency component.

27. The apparatus of claim 14, wherein the concentration calculation unit comprises:

an address generator for generating an address based upon the relation between invasively measured hemoglobin concentrations input externally and the at least one ratio input from the ratio calculation unit and outputting the generated address; and

a look-up table for predicting and outputting one of the invasively measured hemoglobin concentrations previously stored therein as the hemoglobin concentration in response to the address input from the address generator.